Summaries for patients. Trial of a drug to decrease the risk for heart disease in patients with mild kidney failure.
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000401:mortality / Q000517:prevention & control*; D003404:Creatinine / Q000097:blood; D048909:Diabetes Complications; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D011379:Prognosis; D017257:Ramipril / Q000009:adverse effects / Q000627:therapeutic use*; D051437:Renal Insufficiency / Q000150:complications*; D012307:Risk Factors; D014652:Vascular Diseases / Q000150:complications* / Q000188:drug therapy
D000806:Angiotensin-Converting Enzyme Inhibitors; D003404:Creatinine; D017257:Ramipril